Medical Conference Posters/Presentations

• Society for Immunotherapy of Cancer (SITC) 2022 Annual Meeting
  • ATRC-101 Trial-in-Progress Poster
  • EphA2 Poster

• World ADC Conference 2022
  • APN-497444 Poster
  • EphA2 Poster

• Keystone Symposia Conference: Antibodies as Drugs
  • Anti-SARS-CoV-2 Antibodies Poster

• 2021 San Antonio Breast Cancer Symposium (SABCS)
  • Immune Repertoire Poster

• Society for Immunotherapy of Cancer (SITC) 2021 Annual Meeting
  • ATRC-101 + Chemotherapy Preclinical Poster
  • ATRC-101 Trial-in-Progress Poster

• Atreca at the American Association for Cancer Research (AACR) 2021 Annual Meeting
  • ATRC-101 Trial-in-Progress Poster

• Society for Immunotherapy of Cancer (SITC) 2020 Annual Meeting
  • ATRC-101 + Anti-PD1 Preclinical Poster
  • ATRC-101 Preclinical Poster

• Atreca at the American Society of Clinical Oncology (ASCO) 2020 Virtual Conference
  • ATRC-101 Trial-in-Progress Poster

• Society for Immunotherapy of Cancer (SITC) 2019 Annual Meeting
  • ATRC-101 Preclinical Poster

Publications

• Proceedings of the National Academy of Sciences (PNAS), May 2022
  • Mobilization of innate and adaptive antitumor immune responses by the RNP-targeting antibody ATRC-101 (Scholz, et al.)

• Clinical Immunology, February 2018
  • Non-progressing cancer patients have persistent B cell responses expressing shared antibody paratopes that target public tumor antigens (DeFalco, et al.)

R&D Webinars

• April 2022 Pipeline-Focused R&D Day
• June 2020 ATRC-101 Preclinical Webinar